HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Con Panousis Selected Research
Con Panousis Research Topics
Disease
3
Thrombosis (Thrombus)
11/2021 - 02/2014
3
Inflammation (Inflammations)
01/2020 - 01/2016
2
Idiopathic Pulmonary Fibrosis
01/2022 - 05/2014
2
Neoplasms (Cancer)
01/2020 - 08/2003
2
Arthritis (Polyarthritis)
01/2018 - 12/2016
2
Hemorrhage
01/2016 - 02/2014
2
Asthma (Bronchial Asthma)
01/2016 - 05/2014
1
Atherosclerotic Plaque (Atheroma)
01/2022
1
Abdominal Aortic Aneurysm
01/2022
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1
Atherosclerosis
01/2022
1
Pathologic Constriction (Stenosis)
01/2022
1
Hemophilia A (Haemophilia)
11/2021
1
Glomerulonephritis
01/2021
1
Rupture
01/2020
1
Aneurysm (Aneurysms)
01/2020
1
Autoimmune Diseases (Autoimmune Disease)
01/2018
1
Lung Injury
01/2017
1
Human Influenza (Influenza)
12/2016
1
Rheumatoid Arthritis
12/2016
1
Joint Diseases (Joint Disease)
12/2016
1
Infections
12/2016
1
Neuroinflammatory Diseases
01/2016
1
Brain Ischemia (Cerebral Ischemia)
01/2016
1
Stroke (Strokes)
01/2016
1
Reperfusion Injury
01/2016
1
Edema (Dropsy)
08/2015
1
Hereditary Angioedema Type III
08/2015
1
Wounds and Injuries (Trauma)
02/2014
1
Carcinoma (Carcinomatosis)
08/2003
Drug/Important Bio-Agent (IBA)
6
Factor XII (Hageman Factor)
IBA
01/2022 - 02/2014
3
Factor XIIa (Coagulation Factor XIIa)
IBA
01/2022 - 01/2016
3
Cytokines
IBA
01/2018 - 05/2014
2
Complement System Proteins (Complement)
IBA
01/2021 - 01/2018
2
Peptide Hydrolases (Proteases)
FDA Link
08/2015 - 02/2014
2
Neutralizing Antibodies
IBA
08/2015 - 02/2014
1
Angiotensin II
IBA
01/2022
1
Apolipoproteins E (ApoE)
IBA
01/2022
1
Interleukin-6 (Interleukin 6)
IBA
01/2022
1
Monoclonal Antibodies
IBA
01/2022
1
von Willebrand Factor
IBA
11/2021
1
Proteins (Proteins, Gene)
FDA Link
11/2021
1
Albumins
IBA
11/2021
1
Factor VIII (Coagulation Factor VIII)
IBA
11/2021
1
antiglomerular basement membrane antibody
IBA
01/2021
1
Kinins
IBA
01/2020
1
Apolipoproteins
IBA
01/2020
1
ADAM17 Protein
IBA
01/2020
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2020
1
Peptides (Polypeptides)
IBA
01/2020
1
Kallikreins (Kallikrein)
IBA
01/2020
1
Fc Receptors (Fc Receptor)
IBA
01/2018
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2018
1
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2018
1
Histones (Histone)
IBA
01/2017
1
Bleomycin (Blenoxane)
FDA Link
Generic
01/2017
1
Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)
IBA
01/2017
1
Collagen
IBA
12/2016
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
12/2016
1
Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)
IBA
12/2016
1
Steroids
IBA
01/2016
1
Bradykinin
IBA
08/2015
1
Interleukin-13
IBA
05/2014
1
Heparin (Liquaemin)
FDA Link
Generic
02/2014
1
Hemostatics (Antihemorrhagics)
IBA
02/2014
1
Fibrin
IBA
02/2014
1
Anticoagulants
IBA
02/2014
1
A-factor (Streptomyces)
IBA
02/2014
1
ErbB Receptors (EGF Receptor)
IBA
08/2003
1
epidermal growth factor receptor VIII
IBA
08/2003
1
Antigens
IBA
08/2003
1
Hu3S193 monoclonal antibody
IBA
08/2003
1
monoclonal antibody 806
IBA
08/2003
Therapy/Procedure
3
Therapeutics
12/2016 - 08/2003
1
Extracorporeal Membrane Oxygenation
01/2016
1
Extracorporeal Circulation
02/2014